If you are thinking of participating in a weight loss study, one of the first questions you might ask is probably the most important one: “How long am I signing up for?”
This is a completely reasonable question to ask, and the answer is: it depends on the purpose of the study. Some studies are relatively short, while others are longer to help answer questions not just about weight loss but also about weight maintenance, safety, and the long-term effects of changes in the study medication.
So, the answer to the question is not “one size fits all.” Therefore, it is essential to do your research and ask questions whenever you have the chance. This is your chance to get answers to the study’s timeline question.
Why the length of the study varies so much
Clinical trials are not done for the sake of doing them, but to answer a question, such as:
- Does the medication result in weight loss compared to the placebo or the standard treatment?
- How does the medication stack up in terms of side effects over time?
- What are the effects on blood pressure, blood sugar, waist size, or quality of life?
- Do the results last over time, or do they wear off after the medication is stopped?
A study designed to examine the early effects of the medication will be relatively short, while one designed to examine the long-term effects will necessarily be longer.
This is not unique to weight loss studies, but is the case in all clinical research, where the length of the study can be as short as one day or as long as several years.
The timeline most people actually experience
While there are variations across studies, most weight-loss or obesity clinical trials follow a similar format. They have three parts: getting started, active study time, and follow-up.
1) Getting started: from first contact to screening
This is the part of the process that’s often forgotten in the question of “how long does it last?” However, it’s an important phase of the process as it’s where the diaries, appointments, and planning begin.
This phase generally includes an initial interest registration, a call or prescreening, followed by a screening appointment. Sometimes this phase includes two visits. However, the speed of this phase will depend on the study or location. In this phase, the researchers will determine whether it’s appropriate for you to participate in the clinical trial.
2) Active study time: the “main” part of the clinical trial
This is the phase of the clinical trial that most people are referring to when they ask how long a weight loss clinical trial lasts.
For example, most obesity medicine clinical trials are long enough to measure the effects of weight loss and safety over time. In fact, in order to give you an idea of how long these studies are, some of the most important clinical trials in obesity medicine have lasted from one year to one and a half years.
In one of the biggest clinical trials of once-weekly semaglutide, the trial lasted for 68 weeks, or just over 15 months. In another important clinical trial of tirzepatide in obesity, the trial lasted for 72 weeks. In fact, this trial even had an extension phase.
That doesn’t mean all trials are this long, but it does mean there is a reason why many trials aren’t “quick.” If you want to understand long-term weight loss and safety, time is needed.
3) Follow-up: What happens after treatment (or at the end)
Some trials end with a visit, followed by a short follow-up period to ensure safety. Some trials also have a follow-up period, particularly after the end of treatment. This is particularly relevant for trials where the end of treatment is relevant, like with the discontinuation of a drug.
As an example, in a follow-up of a study of semaglutide, after withdrawal of the drug, weight can be regained. This is precisely the type of data that a follow-up period is designed to measure.
As you can see, trials can be long, but there is a reason for this. There is active treatment, but there is also follow-up, and follow-up is important.
What happens at different stages
As you’re trying to visualise this in your life, it can be helpful to know a bit about the different stages of a clinical trial.
In the early stages, there is a screening period, then a baseline period. There is then a period of titration, particularly for medication, where there is a step-up phase. There is also a follow-up period, which can be more or less frequent depending on the stage of the study.
There can also be a period of structured support, particularly for lifestyle changes. The important part is to know, from the start, how many times you have to attend, and what happens if you have to reschedule.
“How long is normal?” (A realistic range)
If you want a rule of thumb, many weight loss trials tend to follow a fairly simple pattern:
- Shorter trials tend to be about early signals or particular results (often weeks or a few months).
- Medium-length trials tend to be about weight loss and safety (often many months, up to a year).
- Longer trials tend to be about what happens after a trial ends or changes (often a year or more, sometimes longer).
The most important thing to remember is that you shouldn’t have to guess. The study should be able to explain what you can expect for study duration, visit frequency, and what it means to be at the end of a study.
The question to ask isn’t really “how long?”
A better question is: “How long is the study, and what happens afterwards?”
This is a far better question to ask because it tends to clarify things for you much more. The question of how long a study is tends to be far more straightforward when you ask it this way.
If you have a job, this is particularly important to you
You should also remember that, while a study is a certain number of months, it’s also a certain number of visits, and that the study’s visit frequency is flexible.
If you have a job, it’s a good idea to ask about visit frequency early on because this is what will ultimately determine whether or not it’s feasible to participate.
A final reassurance
A longer study is not about being locked in without control. You always have the right to ask questions, to be informed, and to opt out if you wish. This is part of the difference between the online hype and the reality of regulated research.
If you are looking into weight-loss clinical trials in the UK, the benefits of choosing a regulated, supported option are clear, especially when the outcome is not just about the results, but about results that are tracked, measured, and known to be safe.
Thinking about taking part?
If you are thinking about obesity clinical trials and want to know more about the options that are currently available, or perhaps those that will be available in the near future, then the best thing to do is to register your interest and talk to the team about the options that are out there. This will help you to get an idea of the study that is best suited to your health background, your diary, and the commitment that you are able to make.
